• Clinically proven to give instant and all-day* dry eye relief with a single drop, SYSTANE® COMPLETE is now preservative-free
  • SYSTANE® COMPLETE Preservative-Free is now widely available starting August 15, 2022

TORONTO , Aug. 15, 2022 /CNW/ – Today Alcon, the global leader in eye care, announced the Canadian launch of the newest addition in order to its innovative portfolio associated with dry eyes products. New SYSTANE® COMPLETE Preservative-Free Lubricant Eye Drops is an all-in-one solution available in an easy-to-use, multi-dose bottle.

The SYSTANE® COMPLETE Preservative-Free formula works for all types of dry eye, hydrating and protecting with one drop. 1 2 3 4 Alcon’s proprietary, nano-droplet technology allows for fast-acting hydration, tear evaporation protection, and long-lasting alleviation for a patient’s eyes. 3

“We’re thrilled to introduce SYSTANE® FULL Preservative-Free to the Canadian market, ” said Chris Gruhn , General Manager regarding Alcon North america . “Research shows that 86 percent of dry eye sufferers have some form of evaporative dry eye 5 yet most eye drops are not designed to address it 6 . For those with dry eyes symptoms but unclear on what type involving dry eye they have, SYSTANE® COMPLETE Preservative-Free can help as it has been clinically demonstrated to provide all day* symptom comfort for all forms of dry eye, hydrating and safeguarding with one drop. ”  1

Moreover, in a long-term clinical trial, dry out eye patients using SYSTANE® COMPLETE four times daily for six months† experienced a statistically and medically significant improvement in symptom scores. Additionally , 20 % of patients treated with SYSTANE® COMPLETE no longer met the criteria‡ that optometrists use to be able to diagnose dry up eye. 7

“Due for you to increased amounts of screen time, many patients are experiencing dry eye, ” stated Dr . Eric DesGroseilliers , optometrist at eyeDOCS Ottawa . “I’m happy to recommend SYSTANE® COMPLETE Preservative-Free as an helpful solution with regard to Canadians’ dry eyes symptoms. ”

SYSTANE® FINISH Preservative-Free will be available nationally in optometry practices, optical retailers, online plus national merchants.

For more information, visit Systane. ca.

* 8 hours
† Signs and symptoms of free of moisture eye were evaluated in a prospective, long-term, double-masked, parallel group, randomized controlled trial for individuals with dry eye disease. Patients instilled SYSTANE® COMPLETE 4 times regular for 6 months (n=99).
‡ According to OSDI (Ocular surface disease index), DEQ-5 (Dry vision questionnaire 5=item), and SANDE (Symptom assessment in dry eye), p ≤ 0. 01.


Refer to help product instructions for complete wear, care and safety information on SYSTANE® products.



About Alcon

Alcon helps people see brilliantly. As the global leader in eye care with the heritage spanning more than seven decades, we offer the broadest portfolio of items to enhance sight and improve people’s lives. Our Surgical and Vision Care products touch the life of more than 260 million individuals in over 140 countries each year living with conditions like cataracts, glaucoma, retinal diseases in addition to refractive errors. Our a lot more than 23, 000 associates are enhancing the quality of life through innovative goods, partnerships with eye care professionals and even programs that will advance access to quality attention care. Learn more at www.alcon.ca . You can also connect along with us on Instagram together with Facebook .

References


1 Silverstein S. Yeu E, Tauber J. et al. Symptom Relief Following a Single Dose connected with Propylene Glycol-Hydroxypropyl Guar Nanoemulsion in Patients with Dry Eye Disease: A Phase IV. Multicenter Trial. Clin Ophthalmol. 2020; 14: 3167-3177. m.


2 Consumer Vision Drop Research, Global Path-To-Purchase; Alcon data on file, 2017.


3 Ketelson H, Rangarajan R. Pre-clinical evaluation of a new novel phospholipid nanoemulsion based lubricant eyesight drops. Poster presented in ARVO 2017, Baltimore, MD.


4 Rangarajan R, Ketelson H. Preclinical evaluation with a new hydroxypropyl-guar phospholipid nanoemulsion-based artificial tear formulation in models of corneal epithelium. J Ocul Pharmacol Ther. 2019; 35(1): 32-37.


5 Lemp MA, Crews LA, Bron AJ, Foulks GN, Sullivan BD. Distribution for aqueous-deficient and additionally evaporative dry eyes in some sort of clinic-based patient cohort: a good retrospective study. Cornea. 2012; 31: 472–478.


6 Alcon data upon file, 2021.


7 Craig JP, et al. Developing evidence-based guidance for the treatment of dry vision disease together with artificial tear supplements: A six-month multicentre, double-masked randomised controlled test. Ocul Surf. 2021; 20: 62-69.

SOURCE Alcon Europe

For further information: Max Mosher, [email protected] , +1 (647) 245-7754

Leave a Reply

Your email address will not be published.